Singapore markets closed

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.69+0.11 (+0.81%)
At close: 04:00PM EDT
13.50 -0.19 (-1.39%)
After hours: 04:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 823.89M
Enterprise value 110.19M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.01
Price/book (mrq)1.17
Enterprise value/revenue 1.21
Enterprise value/EBITDA -0.22

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 3-71.85%
S&P500 52-week change 322.36%
52-week high 359.99
52-week low 310.92
50-day moving average 318.69
200-day moving average 322.24

Share statistics

Avg vol (3-month) 31.05M
Avg vol (10-day) 31.72M
Shares outstanding 560.18M
Implied shares outstanding 660.11M
Float 847.61M
% held by insiders 112.49%
% held by institutions 195.85%
Shares short (15 Apr 2024) 49.31M
Short ratio (15 Apr 2024) 411.22
Short % of float (15 Apr 2024) 423.37%
Short % of shares outstanding (15 Apr 2024) 415.49%
Shares short (prior month 15 Mar 2024) 48.4M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,489.18%

Management effectiveness

Return on assets (ttm)-31.98%
Return on equity (ttm)-54.72%

Income statement

Revenue (ttm)91.06M
Revenue per share (ttm)1.52
Quarterly revenue growth (yoy)139.90%
Gross profit (ttm)N/A
EBITDA -507.26M
Net income avi to common (ttm)-503.14M
Diluted EPS (ttm)-8.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)717.01M
Total cash per share (mrq)11.91
Total debt (mrq)3.31M
Total debt/equity (mrq)0.47%
Current ratio (mrq)12.22
Book value per share (mrq)11.73

Cash flow statement

Operating cash flow (ttm)-424.74M
Levered free cash flow (ttm)-232.9M